Matches in Wikidata for { <http://www.wikidata.org/entity/Q65389671> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q65389671 description "clinical trial" @default.
- Q65389671 description "ensayu clínicu" @default.
- Q65389671 description "klinisch onderzoek" @default.
- Q65389671 description "клінічне випробування" @default.
- Q65389671 name "A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)" @default.
- Q65389671 name "A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder" @default.
- Q65389671 type Item @default.
- Q65389671 label "A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)" @default.
- Q65389671 label "A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder" @default.
- Q65389671 prefLabel "A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR)" @default.
- Q65389671 prefLabel "A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder" @default.
- Q65389671 P1050 Q65389671-6A1CC8EE-51C2-41A9-A276-8CCF75F315F4 @default.
- Q65389671 P1132 Q65389671-BB45D0D7-3C68-4E6A-9EF5-BD8F324C7A9F @default.
- Q65389671 P1476 Q65389671-CDB54225-C131-4FC7-84F9-C6E6124B3C62 @default.
- Q65389671 P17 Q65389671-01DB3A37-EC01-4288-95EE-15587DE8D5DA @default.
- Q65389671 P17 Q65389671-0503E7EA-4CF8-4A1D-8E88-44287BC8AF24 @default.
- Q65389671 P17 Q65389671-0D231B30-091A-44BD-BA31-6F061AE0AF9E @default.
- Q65389671 P17 Q65389671-2C56E42A-7374-4908-86A0-7E5AFBF0C2C0 @default.
- Q65389671 P17 Q65389671-3EAB2AB2-4679-42FA-BC96-7D661E167CA7 @default.
- Q65389671 P17 Q65389671-8D20BAB0-2165-4CE2-BB15-59EF829E1AC2 @default.
- Q65389671 P17 Q65389671-AD2DFE1A-60FD-4BBE-BFB6-675A29002109 @default.
- Q65389671 P17 Q65389671-C0D3F47B-0FDE-4F84-980D-512B47F7771B @default.
- Q65389671 P17 Q65389671-EC83EA9D-117E-400D-A26A-4A9C1E1A3161 @default.
- Q65389671 P17 Q65389671-F2A54DB3-DFBD-4BD1-966D-7EFDBF5FCD02 @default.
- Q65389671 P1813 Q65389671-ED5F13E6-AEA8-4B7E-8833-4259894DC5A6 @default.
- Q65389671 P2899 Q65389671-1FFDA0FB-3FB0-4A2A-B6FE-9B127DA7C58F @default.
- Q65389671 P3098 Q65389671-8C13A613-905A-4F3A-B0EB-4D9A88E119D2 @default.
- Q65389671 P31 Q65389671-A193E389-F787-4CFB-AB14-7D4317C9F49D @default.
- Q65389671 P580 Q65389671-45F2D3EE-EB4E-47CF-B3D7-D420C1FE04C1 @default.
- Q65389671 P582 Q65389671-38BE2989-0CE8-4421-83A8-1F8E7FBD4AA2 @default.
- Q65389671 P6099 Q65389671-32CE8E1F-FD63-473B-B6CF-FA66411698F9 @default.
- Q65389671 P8363 Q65389671-91E0E777-E666-43AB-BF1A-B63829065EFC @default.
- Q65389671 P1050 Q281490 @default.
- Q65389671 P1132 "+643" @default.
- Q65389671 P1476 "Solifenacin Succinate in a Flexible Dose Regimen With Simplified Bladder Training Versus Solifenacin Succinate in a Flexible Dose Regimen Alone in a Prospective, Randomized, Parallel Group, Overactive Bladder Symptom Study" @default.
- Q65389671 P17 Q142 @default.
- Q65389671 P17 Q213 @default.
- Q65389671 P17 Q28 @default.
- Q65389671 P17 Q29 @default.
- Q65389671 P17 Q31 @default.
- Q65389671 P17 Q36 @default.
- Q65389671 P17 Q38 @default.
- Q65389671 P17 Q408 @default.
- Q65389671 P17 Q43 @default.
- Q65389671 P17 Q55 @default.
- Q65389671 P1813 "SOLAR" @default.
- Q65389671 P2899 "+18" @default.
- Q65389671 P3098 "NCT00337558" @default.
- Q65389671 P31 Q30612 @default.
- Q65389671 P580 "2006-05-01T00:00:00Z" @default.
- Q65389671 P582 "2007-05-01T00:00:00Z" @default.
- Q65389671 P6099 Q42825046 @default.
- Q65389671 P8363 Q78089383 @default.